Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Cedric Hermans and Victor Jiménez-Yuste.
Cedric Hermans
Connection Strength
0.478
Victor Jiménez-Yuste
  1. Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study. Lancet Haematol. 2019 Jun; 6(6):e295-e305.
    View in: PubMed
    Score: 0.205
  2. Outcome measures for adult and pediatric hemophilia patients with inhibitors. Eur J Haematol. 2017 Aug; 99(2):103-111.
    View in: PubMed
    Score: 0.178
  3. Practical aspects of extended half-life products for the treatment of haemophilia. Ther Adv Hematol. 2018 Sep; 9(9):295-308.
    View in: PubMed
    Score: 0.049
  4. Haemophilia B: Where are we now and what does the future hold? Blood Rev. 2018 01; 32(1):52-60.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.